GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Corp (XKRX:006280) » Definitions » ROCE %

Green Cross (XKRX:006280) ROCE % : 10.77% (As of Sep. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Green Cross ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Green Cross's annualized ROCE % for the quarter that ended in Sep. 2024 was 10.77%.


Green Cross ROCE % Historical Data

The historical data trend for Green Cross's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross ROCE % Chart

Green Cross Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 7.36 10.66 5.35 0.07

Green Cross Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.42 -4.49 -4.99 0.38 10.77

Green Cross ROCE % Calculation

Green Cross's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1348.424/( ( (2525537.081 - 540738.447) + (2643313.917 - 868916.639) )/ 2 )
=1348.424/( (1984798.634+1774397.278)/ 2 )
=1348.424/1879597.956
=0.07 %

Green Cross's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=214367.676/( ( (2729524.436 - 754084.426) + (2795349.213 - 791137.863) )/ 2 )
=214367.676/( ( 1975440.01 + 2004211.35 )/ 2 )
=214367.676/1989825.68
=10.77 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Cross  (XKRX:006280) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Green Cross ROCE % Related Terms

Thank you for viewing the detailed overview of Green Cross's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Business Description

Traded in Other Exchanges
N/A
Address
303 Bojeong-Dong, Giheung-Gu, Yongin, Gyeonggi, KOR, 449-070
Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

Green Cross Headlines

No Headlines